Polymeric trileaflet prosthetic heart valves: Evolution and path to clinical reality

Thomas E. Claiborne, Marvin J Slepian, Syed Hossainy, Danny Bluestein

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Present prosthetic heart valves, while hemodynamically effective, remain limited by progressive structural deterioration of tissue valves or the burden of chronic anticoagulation for mechanical valves. An idealized valve prosthesis would eliminate these limitations. Polymeric heart valves (PHVs), fabricated from advanced polymeric materials, offer the potential of durability and hemocompatibility. Unfortunately, the clinical realization of PHVs to date has been hampered by findings of in vivo calcification, degradation and thrombosis. Here, the authors review the evolution of PHVs, evaluate the state of the art of this technology and propose a pathway towards clinical reality. In particular, the authors discuss the development of a novel aortic PHV that may be deployed via transcatheter implantation, as well as its optimization via device thrombogenicity emulation.

Original languageEnglish (US)
Pages (from-to)577-594
Number of pages18
JournalExpert Review of Medical Devices
Volume9
Issue number6
DOIs
StatePublished - Nov 2012

Fingerprint

Heart valve prostheses
Critical Pathways
Heart Valves
Deterioration
Durability
Prostheses and Implants
Tissue
Thrombosis
Degradation
Technology
Polymers
Equipment and Supplies

Keywords

  • aortic stenosis
  • device thrombogenicity emulation
  • nano-composite
  • platelet activation
  • polyurethane
  • SIBS
  • transcatheter valve replacement

ASJC Scopus subject areas

  • Surgery
  • Biomedical Engineering

Cite this

Polymeric trileaflet prosthetic heart valves : Evolution and path to clinical reality. / Claiborne, Thomas E.; Slepian, Marvin J; Hossainy, Syed; Bluestein, Danny.

In: Expert Review of Medical Devices, Vol. 9, No. 6, 11.2012, p. 577-594.

Research output: Contribution to journalArticle

Claiborne, Thomas E. ; Slepian, Marvin J ; Hossainy, Syed ; Bluestein, Danny. / Polymeric trileaflet prosthetic heart valves : Evolution and path to clinical reality. In: Expert Review of Medical Devices. 2012 ; Vol. 9, No. 6. pp. 577-594.
@article{f81ceae3f1c64b4c9c625470b34f019c,
title = "Polymeric trileaflet prosthetic heart valves: Evolution and path to clinical reality",
abstract = "Present prosthetic heart valves, while hemodynamically effective, remain limited by progressive structural deterioration of tissue valves or the burden of chronic anticoagulation for mechanical valves. An idealized valve prosthesis would eliminate these limitations. Polymeric heart valves (PHVs), fabricated from advanced polymeric materials, offer the potential of durability and hemocompatibility. Unfortunately, the clinical realization of PHVs to date has been hampered by findings of in vivo calcification, degradation and thrombosis. Here, the authors review the evolution of PHVs, evaluate the state of the art of this technology and propose a pathway towards clinical reality. In particular, the authors discuss the development of a novel aortic PHV that may be deployed via transcatheter implantation, as well as its optimization via device thrombogenicity emulation.",
keywords = "aortic stenosis, device thrombogenicity emulation, nano-composite, platelet activation, polyurethane, SIBS, transcatheter valve replacement",
author = "Claiborne, {Thomas E.} and Slepian, {Marvin J} and Syed Hossainy and Danny Bluestein",
year = "2012",
month = "11",
doi = "10.1586/erd.12.51",
language = "English (US)",
volume = "9",
pages = "577--594",
journal = "Expert Review of Medical Devices",
issn = "1743-4440",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Polymeric trileaflet prosthetic heart valves

T2 - Evolution and path to clinical reality

AU - Claiborne, Thomas E.

AU - Slepian, Marvin J

AU - Hossainy, Syed

AU - Bluestein, Danny

PY - 2012/11

Y1 - 2012/11

N2 - Present prosthetic heart valves, while hemodynamically effective, remain limited by progressive structural deterioration of tissue valves or the burden of chronic anticoagulation for mechanical valves. An idealized valve prosthesis would eliminate these limitations. Polymeric heart valves (PHVs), fabricated from advanced polymeric materials, offer the potential of durability and hemocompatibility. Unfortunately, the clinical realization of PHVs to date has been hampered by findings of in vivo calcification, degradation and thrombosis. Here, the authors review the evolution of PHVs, evaluate the state of the art of this technology and propose a pathway towards clinical reality. In particular, the authors discuss the development of a novel aortic PHV that may be deployed via transcatheter implantation, as well as its optimization via device thrombogenicity emulation.

AB - Present prosthetic heart valves, while hemodynamically effective, remain limited by progressive structural deterioration of tissue valves or the burden of chronic anticoagulation for mechanical valves. An idealized valve prosthesis would eliminate these limitations. Polymeric heart valves (PHVs), fabricated from advanced polymeric materials, offer the potential of durability and hemocompatibility. Unfortunately, the clinical realization of PHVs to date has been hampered by findings of in vivo calcification, degradation and thrombosis. Here, the authors review the evolution of PHVs, evaluate the state of the art of this technology and propose a pathway towards clinical reality. In particular, the authors discuss the development of a novel aortic PHV that may be deployed via transcatheter implantation, as well as its optimization via device thrombogenicity emulation.

KW - aortic stenosis

KW - device thrombogenicity emulation

KW - nano-composite

KW - platelet activation

KW - polyurethane

KW - SIBS

KW - transcatheter valve replacement

UR - http://www.scopus.com/inward/record.url?scp=84871362140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871362140&partnerID=8YFLogxK

U2 - 10.1586/erd.12.51

DO - 10.1586/erd.12.51

M3 - Article

C2 - 23249154

AN - SCOPUS:84871362140

VL - 9

SP - 577

EP - 594

JO - Expert Review of Medical Devices

JF - Expert Review of Medical Devices

SN - 1743-4440

IS - 6

ER -